MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.2800
+0.0500 (21.74%)
At close: Jul 14, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 2.04 million as of July 14, 2026. Its market cap has increased by 14.59% in one year.
Market Cap
2.04M
Enterprise Value
4.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 2.04M, a decrease of -97.45%. That is a compound annual growth rate of -68.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.04M | -65.97% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 4.08M |
| Grey Matters Health | 3.46M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| Rakovina Therapeutics | 2.69M |
| ASEP Medical Holdings | 2.06M |
| Appili Therapeutics | 1.99M |
| Doseology Sciences | 1.80M |